Get the Stockscreener App
3.64
1.89%
-0.07
After Hours:
3.65
0.010
+0.27%
Ataibeckley Inc stock is traded at $3.64, with a volume of 2.11M.
It is down -1.89% in the last 24 hours and down -13.95% over the past month.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
See More
Previous Close:
$3.71
Open:
$3.72
24h Volume:
2.11M
Relative Volume:
0.43
Market Cap:
$1.32B
Revenue:
$2.59M
Net Income/Loss:
$-137.89M
P/E Ratio:
-4.4938
EPS:
-0.81
Net Cash Flow:
$-69.76M
1W Performance:
-2.93%
1M Performance:
-13.95%
6M Performance:
+34.81%
1Y Performance:
+161.87%
1-Day Range:
$3.61
$3.74
1-Week Range:
$3.60
$3.8453
52-Week Range:
$1.15
$6.75
Ataibeckley Inc Stock (ATAI) Company Profile
Name
Ataibeckley Inc
Sector
Industry
Phone
49 89 2153 9035
Address
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Compare ATAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
3.64 | 1.35B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jul-29-25 | Initiated | Oppenheimer | Outperform |
| Nov-18-24 | Reiterated | H.C. Wainwright | Buy |
| Apr-03-24 | Upgrade | Maxim Group | Hold → Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Nov-30-21 | Initiated | Maxim Group | Buy |
| Nov-11-21 | Initiated | ROTH Capital | Buy |
| Oct-18-21 | Initiated | H.C. Wainwright | Buy |
| Sep-01-21 | Initiated | Jefferies | Buy |
| Jul-13-21 | Initiated | Berenberg | Buy |
| Jul-13-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | Cantor Fitzgerald | Buy |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jul-13-21 | Initiated | Cowen | Outperform |
| Jul-13-21 | Initiated | Credit Suisse | Outperform |
| Jul-13-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-08-21 | Initiated | Aegis Capital | Buy |
View All
Ataibeckley Inc Stock (ATAI) Latest News
Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift - simplywall.st
Is AtaiBeckley (ATAI) Turning Psychedelic Trial Momentum Into a Durable Mental Health Moat? - simplywall.st
Interesting ATAI Call Options For March 20th - Nasdaq
Atai Beckley announces presentations at ACNP - TipRanks
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… - Proactive financial news
AtaiBeckley shares clinical and preclinical data at ACNP Annual Meeting - Proactive Investors
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation - Investing News Network
AtaiBeckley Inc. Showcases Breakthrough Findings on BPL-003 for Treatment-Resistant Depression at ACNP Annual Meeting - Quiver Quantitative
Single-dose nasal spray shows rapid effect in hard-to-treat depression - Stock Titan
A Look At AtaiBeckley (ATAI) Valuation After Phase 2b Progress And Delaware Redomiciliation - simplywall.st
Atai Beckley N.V. (ATAI) is a Buy on Mental Therapeutics Opportunities - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
AtaiBeckley Completes Redomiciliation to the United States - Investing News Network
New Strong Sell Stocks for Jan. 13 - The Globe and Mail
atai Life Sciences stock rating reiterated by Cantor Fitzgerald - Investing.com
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - Investing News Network
AtaiBeckley Added to the Nasdaq Biotechnology Index - Investing News Network
Is It Too Late To Reassess AtaiBeckley (ATAI) After A 150% One Year Rally? - simplywall.st
Is It Too Late To Consider AtaiBeckley (ATAI) After A 145% One-Year Surge? - Yahoo Finance
Atai Beckley CEO says entering 2026 with ‘meaningful momentum’ - The Globe and Mail
AtaiBeckley outlines 2026 mental health treatment pipeline milestones By Investing.com - Investing.com Nigeria
Small cap wrap: AtaiBeckley, MustGrow Biologics, Silver Range Resources... - Proactive Investors
Needham Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
AtaiBeckley outlines 2026 mental health treatment pipeline milestones - Investing.com
AtaiBeckley Inc Provides 2026 Outlook and Clinical Updates Ahead of J.P. Morgan Healthcare Conference - Quiver Quantitative
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference - FinancialContent
AtaiBeckley issues 2026 outlook, flags multiple clinical milestones - Proactive financial news
Redomiciliation And Deregistration Move Could Be A Game Changer For AtaiBeckley (ATAI) - simplywall.st
Free float of AtaiBeckley Inc. – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Earnings and Revenue – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Earnings and Revenue – LS:A41WEP - TradingView — Track All Markets
AtaiBeckley Inc. Income Statement – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Revenue Breakdown – LS:A41WEP - TradingView — Track All Markets
AtaiBeckley Inc. Cash Flow – FWB:B72 - TradingView — Track All Markets
Diluted net income available to common stockholders of AtaiBeckley Inc. – GETTEX:B72 - TradingView — Track All Markets
AtaiBeckley Inc. Financial Disclosures & Filings - TradingView — Track All Markets
AtaiBeckley Inc. Statistics – XETR:B72 - TradingView — Track All Markets
AtaiBeckley Inc. Balance Sheet – FWB:B72 - TradingView — Track All Markets
Total operating expenses of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
Cash per share of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
AtaiBeckley (ATAI) Valuation Check As US Redomiciliation Marks A New Phase - simplywall.st
AtaiBeckley Inc. Revenue Breakdown – XETR:B72 - TradingView — Track All Markets
Number of employees of AtaiBeckley Inc. – XETR:B72 - TradingView — Track All Markets
Gross profit of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
EBIT per share of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
Enterprise value of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
Basic earnings per share (basic EPS) of AtaiBeckley Inc. – GETTEX:B72 - TradingView — Track All Markets
Diluted net income available to common stockholders of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
Inventory turnover of ATAIBECKLEY INC. O.N. – FWB:B72 - TradingView — Track All Markets
ATAIBECKLEY INC. O.N. Earnings and Revenue – FWB:B72 - TradingView — Track All Markets
Optimism flows from pot to psychedelics: Atai Beckley, Supernus stocks rise after analyst flags positive tailwinds from Trump’s marijuana order - MSN
Ataibeckley Inc Stock (ATAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.73%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):